We respond to the critical challenges of healthcare — we create new, we foresee the future, we find solutions
Caring for the environment
- Sterile closed full cycle production of antibiotics without contact with the environment
- Equipment of the highest ecological class for the synthesis of substances
- Sanitary area around the plant
- Continuous monitoring of soil and air by independent laboratories
Corporate governance
- Long term strategy based on sustainable development principles
- Information disclosure and business transparency
- Contribution to ensuring national pharmaceutical safety through the development of own synthesis of substances and the development of innovative medicines
Social responsibility
- As an employer and contributor to the modern economy, we prioritize our social responsibilities by fostering partnerships with educational institutions to promote scientific and technical innovation.
- We support the development of future talent through dedicated departments and research laboratories, providing students and researchers with hands-on learning opportunities.
- Our commitment extends to ensuring social stability and offering comprehensive benefits for our employees and their families, reflecting our dedication to creating a positive and sustainable impact within the communities we serve.
Global Footprint
New drugs at various phases of development and approval
Long term cooperation with the CIS countries:
Kazakhstan, Kyrgyzstan, Azerbaijan, Uzbekistan, Georgia, Armenia, Moldova
Development of mutually beneficial relationships with
European Union, Persian Gulf countries, China, Vietnam, Mongolia, Latin America countries
